PDGF in gliomas: more than just a growth factor?

References

• Heldin CH, Westermark B, Wasteson A. Platelet-derived growth factor: purification and partial characterization. Proc Natl Acad Sci USA. 1979;76:3722–6.
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992;70:389–99.
   PubMed Web of Science ®Google Scholar
• Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45:319–26.
   PubMed Web of Science ®Google Scholar
• Louis DN, Gusella JF. A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet. 1995;11:412–5.
   PubMed Web of Science ®Google Scholar
• Furnari FB, Huang HJ, Cavenee WK. Genetics and malignant progression of human brain tumours. Cancer Surv. 1995;25:233–75.
   PubMedGoogle Scholar
• Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 2001;15:1913–25.
   PubMed Web of Science ®Google Scholar
• Lehti K, Rose NF, Valavaara S, Weiss SJ, Keski-Oja J. MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. J Cell Sci. 2009;122:126–35.
   Google Scholar
• Aguirre A, Rubio ME, Gallo V. Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature. 2010;467:323–7.
   PubMed Web of Science ®Google Scholar
• Lillien L, Raphael HBMP and FGF regulate the development of EGF-responsive neural progenitor cells. Development. 2000;127:4993–5005.
   PubMed Web of Science ®Google Scholar
• Cras-Meneur C, Elghazi L, Czernichow P, Scharfmann R. Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro: a balance between proliferation and differentiation. Diabetes. 2001;50:1571–9.
   PubMed Web of Science ®Google Scholar
• Noble M, Barnett SC, Bogler O, Land H, Wolswijk G, Wren D. Control of division and differentiation in oligodendrocyte-type-2 astrocyte progenitor cells. Ciba Found Symp. 1990;150:227–43; discussion 44–9.
   PubMedGoogle Scholar
• Bogler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA. 1990;87:6368–72.
   PubMed Web of Science ®Google Scholar
• Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature. 1988;333:560–2.
   PubMed Web of Science ®Google Scholar
• Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature. 1988;333:562–5.
   PubMed Web of Science ®Google Scholar
• Redwine JM, Armstrong RC. In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J Neurobiol. 1998;37:413–28.
   PubMedGoogle Scholar
• Redwine JM, Blinder KL, Armstrong RC. In situ expression of fibroblast growth factor receptors by oligodendrocyte progenitors and oligodendrocytes in adult mouse central nervous system. J Neurosci Res. 1997;50:229–37.
   PubMed Web of Science ®Google Scholar
• Silberstein GB, Daniel CW. Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science. 1987;237:291–3.
   PubMedGoogle Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.
   PubMed Web of Science ®Google Scholar
• Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA. 2008;105:2883–8.
   PubMed Web of Science ®Google Scholar
• Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 2008;26:1276–84.
   PubMed Web of Science ®Google Scholar
• Huangfu D, Osafune K, Maehr R, Guo W, Eijkelenboom A, Chen S, Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol. 2008;26:1269–75.
   PubMed Web of Science ®Google Scholar
• Morrison SJ, Kimble J. Asymmetric and symmetric stem-cell divisions in development and cancer. Nature. 2006;441:1068–74.
   PubMed Web of Science ®Google Scholar
• Takuwa N, Fukui Y, Takuwa Y. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol. 1999;19:1346–58.
   PubMed Web of Science ®Google Scholar
• Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 1997;275:661–5.
   PubMed Web of Science ®Google Scholar
• Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231–41.
   PubMed Web of Science ®Google Scholar
• Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 1995;267:2003–6.
   PubMed Web of Science ®Google Scholar
• Kulik G, Weber MJ. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I. Mol Cell Biol. 1998;18:6711–18.
   PubMed Web of Science ®Google Scholar
• Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997;11:701–13.
   PubMed Web of Science ®Google Scholar
• Araki S, Shimada Y, Kaji K, Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 1990;168:1194–200.
   PubMed Web of Science ®Google Scholar
• Rawson CL, Loo DT, Duimstra JR, Hedstrom OR, Schmidt EE, Barnes DW. Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation. J Cell Biol. 1991;113:671–80.
   PubMed Web of Science ®Google Scholar
• Jackson EL, Garcia-Verdugo JM, Gil-Perotin S, Roy M, Quinones-Hinojosa A, VandenBerg S, PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron. 2006;51:187–99.
   PubMed Web of Science ®Google Scholar
• Cairns J. Mutation selection and the natural history of cancer. Nature. 1975;255:197–200.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
   PubMed Web of Science ®Google Scholar
• Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864–70.
   PubMed Web of Science ®Google Scholar
• Woo RA, Poon RY. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev. 2004;18:1317–30.
   PubMed Web of Science ®Google Scholar
• Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature. 2005;434:907–13.
   PubMed Web of Science ®Google Scholar
• Westermark UK, Lindberg N, Roswall P, Brasater D, Helgadottir HR, Hede SM, RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability. Neuro Oncol. 2011;13:1277–87.
   PubMed Web of Science ®Google Scholar
• Westermark B, Nister M, Heldin CH. Growth factors and oncogenes in human malignant glioma. Neurol Clin. 1985;3:785–99.
   PubMed Web of Science ®Google Scholar
• Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 1983;221:275–7.
   PubMed Web of Science ®Google Scholar
• Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnsson A, Wasteson A, Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature. 1983;304:35–9.
   PubMed Web of Science ®Google Scholar
• King CR, Giese NA, Robbins KC, Aaronson SA. In vitro mutagenesis of the v-sis transforming gene defines functional domains of its growth factor-related product. Proc Natl Acad Sci USA. 1985:82:5295–9.
   Google Scholar
• Westermark B, Heldin CH. Platelet-derived growth factor as a mediator of normal and neoplastic cell proliferation. Med Oncol Tumor Pharmacother. 1986;3:177–83.
   PubMedGoogle Scholar
• Johnsson A, Heldin CH, Wasteson A, Westermark B, Deuel TF, Huang JS, The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J. 1984;3:921–8.
   PubMed Web of Science ®Google Scholar
• Goustin AS, Leof EB, Shipley GD, Moses HL. Growth factors and cancer. Cancer Res. 1986;46:1015–29.
   PubMed Web of Science ®Google Scholar
• Weinberg RA. The action of oncogenes in the cytoplasm and nucleus. Science. 1985;230:770–6.
   PubMed Web of Science ®Google Scholar
• Deuel TF. Polypeptide growth factors: roles in normal and abnormal cell growth. Annu Rev Cell Biol. 1987;3:443–92.
   PubMedGoogle Scholar
• Press RD, Misra A, Samols D, Goldthwait DA, Mapstone TB. Major structural alterations of the c-sis gene are not observed in a series of tumors of the human central nervous system. J Neurooncol. 1989;7:345–56.
   PubMed Web of Science ®Google Scholar
• Chompret A, Kannengiesser C, Barrois M, Terrier P, Dahan P, Tursz T, PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology. 2004;126:318–21.
   PubMed Web of Science ®Google Scholar
• Pasini B, Matyakhina L, Bei T, Muchow M, Boikos S, Ferrando B, Multiple gastrointestinal stromal and other tumors caused by platelet-derived growth factor receptor alpha gene mutations: a case associated with a germline V561D defect. J Clin Endocrinol Metab. 2007;92:3728–32.
   PubMed Web of Science ®Google Scholar
• de Raedt T, Cools J, Debiec-Rychter M, Brems H, Mentens N, Sciot R, Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA. Gastroenterology. 2006;131:1907–12.
   PubMed Web of Science ®Google Scholar
• Ozawa T, Brennan CW, Wang L, Squatrito M, Sasayama T, Nakada M, PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev. 2010;24:2205–18.
   PubMed Web of Science ®Google Scholar
• Pech M, Gazit A, Arnstein P, Aaronson SA. Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene. Proc Natl Acad Sci USA. 1989;86:2693–7.
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Hesselager G, Nister M, Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 1998;58:5275–9.
   PubMed Web of Science ®Google Scholar
• Calzolari F, Appolloni I, Tutucci E, Caviglia S, Terrile M, Corte G, Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis. Neoplasia. 2008;10:1373–82.
   PubMed Web of Science ®Google Scholar
• Tchougounova E, Kastemar M, Brasater D, Holland EC, Westermark B, Uhrbom L. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Oncogene. 2007;26:6289–96.
   PubMed Web of Science ®Google Scholar
• Hesselager G, Uhrbom L, Westermark B, Nister M. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res. 2003;63:4305–9.
   PubMed Web of Science ®Google Scholar
• Reardon DA, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. Br J Cancer. 2009;101:1995–2004.
   PubMed Web of Science ®Google Scholar
• Razis E, Selviaridis P, Labropoulos S, Norris JL, Zhu MJ, Song DD, Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment. Clin Cancer Res. 2009;15:6258–66.
   PubMed Web of Science ®Google Scholar
• Paulsson J, Lindh MB, Jarvius M, Puputti M, Nister M, Nupponen NN, Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma. Int J Cancer. 2011;128:1981–8.
   PubMed Web of Science ®Google Scholar
• Holmen SL, Williams BO. Essential role for Ras signaling in glioblastoma maintenance. Cancer Res. 2005;65:8250–5.
   PubMed Web of Science ®Google Scholar
• Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Essential role for oncogenic Ras in tumour maintenance. Nature. 1999;400:468–72.
   PubMed Web of Science ®Google Scholar
• Felsher DW, Bishop JM. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell. 1999;4:199–207.
   PubMed Web of Science ®Google Scholar
• Druker BJ. Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML. Oncogene. 2002;21:8541–6.
   PubMed Web of Science ®Google Scholar
• Uhrbom L, Nerio E, Holland EC. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nat Med. 2004;10:1257–60.
   PubMed Web of Science ®Google Scholar
• Hambardzumyan D, Amankulor NM, Helmy KY, Becher OJ, Holland EC. Modeling adult gliomas using RCAS/t-va technology. Transl Oncol. 2009;2:89–95.
   PubMed Web of Science ®Google Scholar
• Hambardzumyan D, Squatrito M, Carbajal E, Holland EC. Glioma formation, cancer stem cells, and akt signaling. Stem Cell Rev. 2008;4:203–10.
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98–110.
   PubMed Web of Science ®Google Scholar